Molecular Biology Enzymes Market - Technological Advancements in the Life Science Industry

Objectives of the Study:

# To define and measure the global molecular biology enzymes and kits & reagents market on the basis of product, application, end user, and region

# To identify key micromarkets and their drivers within the global molecular biology enzymes and kits & reagents market, which are expected to offer impressive growth opportunities in the coming years

# To identify trends and opportunities for stakeholders in the market and provide details of the competitive landscape for major market leaders

# To provide detailed information regarding the major factors influencing market growth (drivers, restraints, challenges, and opportunities)

# To forecast the size of the market segments with respect to four main regions, namely, North America (US and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of APAC), and the Rest of the World (Latin America and Middle East & Africa)

# To analyze the market structure and profile key players in the global molecular biology enzymes and kits & reagents market and comprehensively evaluate their core competencies

# To track and analyze competitive landscape such as market share analysis and competitive leadership

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164131709

Research Methodology:

Top-down and bottom-up approaches were used to validate the size of the global molecular biology enzymes industry and estimate the size of other dependent submarkets. Various secondary sources such as, Biotechnology and Biological Sciences Research Council, European Federation of Biotechnology, Genome Canada, National Human Genome Research Institute, World Health Organization, Federation of Asian and Oceanian Biochemists and Molecular Biologists, World Intellectual Property Organization, Press Releases, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.

Expected Revenue Growth:

The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 Billion by 2022 from USD 6.52 Billion in 2017, at a CAGR of 15.8% during the forecast period.

Growth Influencing Factors:

The key factors driving the growth of this market include increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases and genetic disorders. However, the privacy concerns related to genetic information and limited reimbursements for genetic testing may hinder the growth of this market to a certain extent.

By end user, academic & research institutes to hold the largest market share in 2017

Based on end user, the market is segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and other end users (contract research organizations (CROs), food & beverage companies, and forensic agencies). The academic & research institutes segment is expected to command the largest share of the molecular biology enzymes and kits & reagents market in 2017. The large share of this segment can be attributed to the increasing research activities backed by funding from government and private organizations.

North America to dominate the market in 2017

In 2017, North America is expected to account for the largest share of the molecular biology enzymes and kits & reagents market, followed by Europe, Asia Pacific (APAC), and the Rest of the World (Latin America and the Middle East & Africa). Factors such as increasing research funding for genomics research, rising number of pharmaceutical and biotechnology companies, favorable reimbursement scenario for molecular diagnostics, and growing prevalence of target indications are contributing to the large share of North America.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=164131709

Global Key Players:

The molecular biology enzymes and kits & reagents market is well established owing to the dominance by prominent market players. In 2016, Thermo Fisher (US), Merck (Germany), and Illumina (US) held a share of 70% to 75% of the overall market.

Thermo Fisher Scientific dominated the molecular biology enzymes and kits & reagents market in 2016. The company provides a wide range of products in this market, including transfection reagents, cloning kits, cloning reagents, PCR enzymes & master mixes, PCR reagents, DNA extraction reagents & kits, and genome editing kits.

Merck designs and manufactures products for academic research markets, applied testing customers, the pharmaceutical & biotechnology industry, and molecular diagnostics laboratories. With the acquisition of Sigma-Aldrich Corporation (US), Merck secured the second-leading position in the global market (with a share of 23.1% in 2016). Sigma-Aldrich was one of the leading developers, manufacturers, and distributors of molecular biology enzymes and kits & reagents.

Some of the other players competing in this market are Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

Read Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html